Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

This Combined Synopsis/Solicitation opportunity from Department Of Health And Human Services was posted on August 12, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

CDC Clarivate Meta Core Meta Drug

Closed
75D301-26-Q-79153Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 513210
New
SLED
700028-SS
Solicitation # SRC0000037224
Solicitation SRC0000037224, issued by the State of Alabama Office of the Chief Procurement Officer for Support Services, seeks a bill tracking system for state legislation. The system must provide advanced analytics, data-driven insights, collaborative communication tools, and the ability to compare bills and amendments side-by-side. Key technical requirements include a mobile application with push notifications for instant legislative updates and hearing schedules, customizable reports with note-sharing capabilities, and tracking of legislation via news and social media. The service is initially intended for four users, with the option to add more later, and includes legislative scorecards and statistics on legislator positions. The initial service period is from October 1, 2026, to September 30, 2027, with the possibility of annual renewals for up to five years. The total contract value is capped at 25,000 dollars, including any approved price escalations, which are limited to 5 percent of the annual cost. The contract is governed by the laws of Alabama, with the venue for litigation set in Montgomery. Suppliers must be registered in the Alabama Buys system and provide certifications regarding tax compliance, E-Verify enrollment, and non-debarment. Additionally, the state will not accept click-wrap or browse-wrap agreements unless they are signed by an authorized official.
Support Services

POSTED

about 18 hours ago

DEADLINE

in 3 days
NAICS: 513210
New
Federal
Labview Perpetual Software
Solicitation # N6852027Q1004
The Fleet Readiness Center is soliciting quotations under solicitation N6852027Q1004 for the procurement of National Instruments Corp. LabVIEW perpetual software licenses and related maintenance services to support Fleet Readiness Center East. This is a brand-name only requirement, restricted to National Instruments or its authorized resellers to ensure compatibility with existing RDT&E lab infrastructure. The scope includes software service renewals for several subscription licenses under a Non Concurrent Volume License Agreement, specifically covering the NI LabVIEW+ Suite, LabVIEW FPGA Module, NI Sound and Vibration Toolkit Full, and the NI Automated Test Software Suite. Required deliverables include software upgrades, updates, historical version access for legacy systems, online training, and technical support via phone, chat, and email. The contract is a firm-fixed-price agreement with a period of performance from November 1, 2026, to October 31, 2027. While the procurement is listed as a small business set-aside, a 10 percent price evaluation preference is granted to HUBZone small business concerns. The government will award the contract to the responsible offeror determined to be most advantageous based on price and other factors. All software is delivered electronically, and the contractor must use the Wide Area WorkFlow system for invoicing and payment requests. Quotations must include proof of authorized reseller status and be submitted to the designated point of contact by the specified deadline.
Fleet Readiness Center

POSTED

about 21 hours ago

DEADLINE

in 1 day
NAICS: 513210
New
Federal
Notice of Intent to Sole Source - Telecommunications Analysis Software Support
Solicitation # 192127VHQ6XXX0001
The Department of Homeland Security, through Homeland Security Investigations, intends to award a firm-fixed price contract to Pen-Link, Limited for telecommunications analysis software support for the HSI Technical Operations Center. This sole-source acquisition is based on the proprietary nature of the services and the specific capabilities of the source. The intended period of performance consists of a twelve-month base period followed by four twelve-month option periods. The system must be deployed within the ICE/HSI security boundary and support at least 500 concurrent users across domestic and foreign offices, with the capacity to process and analyze datasets of 10 TB or more, including CALEA formats, social media, and mobile forensics. Key technical requirements include the integration of a Generative AI assistant leveraging Azure AI for natural language queries and visualization, 3D mapping tools, and native integration with the Homeland Security Task Force national web-based deconfliction platform. The contractor must adhere to AGILE development methodology and strictly comply with ICE AI Contract Language to ensure no government data is used to train external AI models. The system must be fully auditable and traceable to prevent vendor lock-in. Interested parties were invited to submit a one-page capability response by October 26, 2026, to be evaluated by the government.
Investigations And Operations Support Dallas

POSTED

about 21 hours ago

DEADLINE

in 5 days

AI Contract Overview

Show more

The Department of Health and Human Services, on behalf of the CDC's Agency for Toxic Substances and Disease Registry, intends to award a firm-fixed-price contract to Clarivate Analytics (US) LLC for the renewal of proprietary MetaCore and MetaDrug software licenses. This web-based bioinformatics suite is essential for the Simulation Science Section to conduct functional analysis, model disease pathways, and visualize biological relationships to investigate environmental exposures to hazardous substances. The proposed period of performance spans five years, from August 18, 2026, through August 17, 2031. Because Clarivate Analytics is the sole owner and provider of these specific tools, the government is pursuing a sole-source acquisition to maintain continuity in existing workflows and avoid disruptions to ongoing toxicological and omics research. While the intent is to award directly to the proprietary provider, interested parties may submit capability statements by August 14, 2026, to demonstrate if an equivalent solution exists that is fully compatible with current scientific methods and data.

General Info

Five-year sole-source contract for Clarivate Analytics to provide MetaCore and MetaDrug software licenses.

Contract Value

$22,319.36

NAICS

513210 - Software Publishers

Place of Performance

Bethesda, MD, 20892, USA

Set-Aside

NONE

Award Issued Date

Documents

1

SOW for Clarivate MetaCore/MetaDrug License Renewal

PDF, High priority: read this firstsow
High

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseClosed
Posted

Combined Synopsis

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → Omas Strategic Buying Center - Information Technology
Contacts2 people available
OfficeRockville, MD, 20857, USA

Full Description

Show more

This is a Notice of Intent, not a request for quotation. No solicitation will be issued, and no quotations will be requested.


The Department of Health and Human Services, Office of Mission Acquisition Solutions (OMAS), on behalf of the Centers for Disease Control and Prevention (CDC), Agency for Toxic Substances and Disease Registry (ATSDR), Office of Innovation and Analytics (OIA), intends to award a firm-fixed-price contract to Clarivate Analytics (US) LLC for the renewal of proprietary Clarivate MetaCore and MetaDrug software licenses.


The purpose of this requirement is to renew ATSDR/OIA’s Clarivate MetaCore/MetaDrug software licenses for continued use by the Simulation Science Section (SSS). The RFQ identifies this requirement as a firm-fixed-price acquisition for Clarivate MetaCore and MetaDrug, Brand Name, All or None. Federal Government resellers must be authorized resellers of the required products/services.


MetaCore/MetaDrug is a web-based bioinformatics suite that allows researchers to upload data analysis results from microarray, next-generation sequencing, metabolic, SAGE, siRNA, microRNA, and screening data. It provides functional analysis to identify the most relevant pathways, networks, and cellular processes in the data. Additionally, gene, protein, compound, pathway, and disease maps are available. The MetaCore/MetaDrug license includes tools for searching and data visualization, enabling identification of relevant biological pathways, networks, and processes in a virtual lab.


Clarivate MetaCore/MetaDrug software will assist ATSDR/OIA/SSS and ATSDR program staff with current computational systems biology tools to help accomplish the agency’s mission to investigate environmental exposures to hazardous substances in communities. With continued use, the software license will help model and understand disease pathways and build unrestricted networks of any size and data type to visualize biological relationships and molecular interactions, annotated with mechanisms, directionality, and effects. The software also supports identification and validation of targets and biomarkers and exploration of biological, chemical, and disease contexts using a comprehensive source of critical data.


The requirement includes the following Clarivate software licenses:


  1. Clarivate MetaCore License Fee
  2. Clarivate MetaDrug License Fee

The contemplated period of performance is August 18, 2026 through August 17, 2031, structured in annual periods as follows:


Year 1: August 18, 2026 – August 17, 2027
Year 2: August 18, 2027 – August 17, 2028
Year 3: August 18, 2028 – August 17, 2029
Year 4: August 18, 2029 – August 17, 2030
Year 5: August 18, 2030 – August 17, 2031


Justification for Sole Source


Clarivate Analytics (US) LLC is the proprietary provider of the required MetaCore and MetaDrug software licenses. Clarivate has certified that Clarivate Companies, including Clarivate Analytics (US) LLC, are the sole owner of MetaCore and MetaDrug and have the exclusive right to license those products/databases.


The required software provides specialized computational systems biology and bioinformatics capabilities needed by ATSDR/OIA/SSS to support ongoing toxicological, omics, and environmental health research activities.


Clarivate MetaCore/MetaDrug provides a web-based platform for functional and network analysis, biological pathway analysis, gene/protein/compound/pathway/disease mapping, and data visualization. These capabilities support the Government’s need to examine, summarize, and interpret available toxicological and omics studies to determine human exposure levels that may be associated with health effects.


The software is used by ATSDR/OIA/SSS to support scientific analyses involving hazardous substances, environmental chemicals, computational toxicology, disease pathway modeling, biomarker identification and validation, and toxicogenomics. Continued use of Clarivate MetaCore/MetaDrug supports consistency of analytical methods, continuity of existing workflows, and continued access to previously developed data, methods, and scientific analyses.


Replacement of the Clarivate MetaCore/MetaDrug software with an alternative product would require transition to a new platform, redevelopment of established workflows, potential migration or recreation of data and analyses, validation of any replacement approach, and retraining of users. These transition activities could disrupt ongoing scientific work and delay ATSDR/OIA/SSS research activities.


Market research conducted in accordance with FAR Part 10 did not identify an alternative commercial software solution capable of meeting the Government’s technical, scientific, and operational requirements in the same manner as Clarivate MetaCore/MetaDrug. The Government requires continued access to the proprietary Clarivate MetaCore and MetaDrug software capabilities to maintain continuity of ongoing computational systems biology and toxicological research activities.


Authority


This acquisition is being conducted under Federal Acquisition Regulation (FAR) Part 13 – Simplified Acquisition Procedures and FAR Part 12 – Acquisition of Commercial Products and Commercial Services. For purchases not exceeding the Simplified Acquisition Threshold, contracting officers may solicit from a single source when the Contracting Officer determines that only one source is reasonably available. Contracts awarded using FAR Part 13 procedures are exempt from the requirements of FAR Part 6 competition requirements.


Submission of Capability Statements


Interested parties capable of providing the same or similar products or services must submit a capability statement electronically. Responses will be considered solely for the purpose of determining whether to conduct a competitive procurement. A determination by the Government not to compete the proposed contract, based upon responses to this notice, is solely within the discretion of the Government.


Capability statements must demonstrate the ability to provide the required Clarivate MetaCore and MetaDrug software licenses, or an equivalent solution, that is fully compatible with ATSDR/OIA/SSS’s existing workflows, data, scientific methods, and ongoing computational toxicology and omics research activities. Capability statements must also demonstrate the ability to provide equivalent functionality for web-based bioinformatics analysis, functional and network analysis, pathway analysis, biological systems modeling, compound and disease mapping, data visualization, and support for toxicological and omics studies without disruption to ongoing ATSDR/OIA/SSS work.




Deadline: August 14, 2026, at 1:00 PM ET

Submit to:
Vera Nordalm
Contract Specialist
Office of Mission Acquisition Solutions (OMAS) 


Email: vera.nordalm@hhs.gov



Copy:
Em’Ria Briscoe
Contracting Officer
Email: EmRia.Briscoe@hhs.gov

More opportunities from Department Of Health And Human Services → Omas Strategic Buying Center - Information Technology

Same awarding agency

NAICS: 541519
New
Federal
Micetro IP Management Renewal
Solicitation # 7571TE27Q00018
Solicitation 7571TE27Q00018 is a request for quote for the renewal of Men and Mice Micetro, a brand-name IP Address Management and Dynamic Host Configuration Protocol platform. Managed by the Omas Strategic Buying Center for the Department of Health and Human Services, the contract supports the National Institute of Allergy and Infectious Diseases by providing centralized management of approximately 23,000 IP addresses across its infrastructure. The primary objective is to ensure network integrity, prevent address conflicts, and maintain uninterrupted vendor support and security patches. The period of performance is scheduled from September 13, 2026, to September 12, 2027. The award will be determined using the Lowest Priced Technically Acceptable procedure, evaluating offerors based on technical acceptability and their discounted open market price. Administrative requirements include electronic invoice submission via the Department of Treasury Invoice Processing Platform, with payments made monthly in arrears upon approval by the Contracting Officer Representative. The contract is designated as FOB Destination and requires offerors to be registered in the System for Award Management and provide certifications regarding federal tax liability and security prohibitions. The primary point of contact for this procurement is Damian Hurge.
Other Computer Related Services

POSTED

about 21 hours ago

DEADLINE

in 5 days
View Details
NAICS: 541611
Federal
Requirements Analysis and Regulatory Workflow ConsultingThe contract entails gathering and analyzing business requirements from FDA CTP reviewers to understand their operational needs, mapping existing regulatory workflows, and translating those into detailed technical specifications for enhancements to the Rhapsody platform. This work requires deep familiarity with FDA regulatory processes and the ability to bridge the gap between clinical and compliance workflows and software development, ensuring that system updates align precisely with regulatory expectations and internal review procedures. The contractor will serve as a critical liaison between domain experts and technical teams, contributing to the continuous improvement of systems used in federal tobacco product review operations. Performance of this subcontract is primarily located in Rockville, Maryland, with a NAICS code of 541611 indicating management, scientific, and technical consulting services. The contract is awarded under the Omas Strategic Buying Center - Information Technology, managed by the Department of Health and Human Services, and is positioned to support ongoing modernization efforts within the FDA’s Center for Tobacco Products. Although no set-aside details or point of contact are provided, the posting date indicates the opportunity was made available in May 2026, suggesting a forward-looking procurement aimed at enhancing institutional capacity with specialized regulatory technology expertise.
Administrative Management and General Management Consulting Services

POSTED

5 months ago

DEADLINE

N/A
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS